Cancer therapy bexmarilimab awakens immune cells to attack tumours that have avoided the detection of the immune system


Researchers at the University of Turku have uncovered how the new bexmarilimab therapy alters the function of immune cells so that they can infiltrate the tumour in cancer patients who do not respond to any other current therapies.

Created 07.12.2023 | Updated 07.12.2023